...
首页> 外文期刊>Caries research >A Membrane-Targeted Peptide Inhibiting PtxA of Phosphotransferase System Blocks Streptococcus mutans
【24h】

A Membrane-Targeted Peptide Inhibiting PtxA of Phosphotransferase System Blocks Streptococcus mutans

机译:抑制磷酸转移酶体系嵌段的膜靶向肽抑制PTXA嵌段链球菌

获取原文
获取原文并翻译 | 示例
           

摘要

Streptococcus mutans, the primary cause of dental caries, takes up carbohydrates through the phosphoenolpyruvate sugar phosphotransferase system (PTS). This study aimed to identify a novel membrane-targeted antimicrobial peptide (AMP) that could also target the L-ascorbate-specific PtxA component of the S. mutans PTS system. C10-KKWW was identified and selected using virtual screening of a lipopeptide library, a minimum inhibiting concentration (MIC) assay, cytotoxicity assays and a hemolysis assay. Surface plasmon resonance confirmed that C10-KKWW had a high binding affinity for PtxA. Combining with scanning electron microscopy and cell permeability assay, it was shown that the effects of C10-KKWW could be attributed to both membrane and PtxA. Wild type (WT) S. mutans, a ptxA deletion mutant (Delta ptxA), and a mutant-complemented strain (CptxA), were cultured consistently in brain heart infusion (BHI) medium, tryptone-vitamin medium supplemented with 15 mM L-ascorbate (TVL), or for 5 h in BHI supplemented with 7.4 mM sodium L-ascorbate. Compared to Delta ptxA, in WT S. mutans and CptxA, C10-KKWW had a stronger MIC (3.9 mu g/mL), and distinctively decreased biofilm viability. The extracellular concentrations of L-ascorbate/sodium L-ascorbate were not changed before and after WT treated with C10-KKWW. L-ascorbate-induced operon genes, or other PTS genes, were significantly suppressed by C10-KKWW. In conclusion, C10-KKWW has been developed; it acts through interaction with the bacterial membrane and interferes with L-ascorbate translocation to inhibit S. mutans growth and eradicate its biofilm. C10-KKWW may be especially effective at optimal oral ascorbate levels. A combination of C10-KKWW with sodium L-ascorbate might also be a novel strategy for dental caries treatment. (c) 2018 S. Karger AG, Basel
机译:链球菌异常,龋齿的主要原因,通过磷酸丙酸胆盐磷翻转酶系统(PTS)占用碳水化合物。本研究旨在鉴定一种新型膜靶向抗微生物肽(AMP),其也可以靶向S.UlastAns PTS系统的L-抗坏血酸特异性PTXA组分。使用脂肽库的虚拟筛选鉴定并选择C10-KKWW,最小抑制浓度(MIC)测定,细胞毒性测定和溶血测定。表面等离子体共振证实C10-KKWW对PTXA具有高结合亲和力。结合扫描电子显微镜和细胞渗透性测定,表明C10-KKWW的效果可归因于膜和PTXA。野生型(WT)S.Ulans,PTXA缺失突变体(Delta PTXA)和突变互补的菌株(CPTXA)始终培养,均匀培养,培养为15mm L-抗坏血酸(TV1),或在补充有7.4mM抗坏血酸钠的BHI中的5小时。与δPTXA相比,在WT S. mutans和CPTXA中,C10-KKWW具有更强的MIC(3.9μg/ ml),并且具有明显降低的生物膜活力。在用C10-KKWW处理之前和之后,不会改变L-抗坏血酸盐/ L-抗坏血酸的细胞外浓度。 L-抗坏血酸诱导的操纵子基因或其他PTS基因被C10-KKWW显着抑制。总之,已开发C10-KKWW;它通过与细菌膜的相互作用作用,并干扰L-抗坏血酸易位,以抑制S. mutans生长并消除其生物膜。 C10-KKWW在最佳的口服抗坏血酸水平上可能特别有效。 C10-KKWW与L型抗坏血酸钠的组合也可能是龋齿治疗的新策略。 (c)2018年S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号